Despite concerns raised by clinicians and ethicists, direct-to-consumer testing for Alzheimer’s disease biomarkers is here, ...

This was the stock's second consecutive day of losses.

Quest Diagnostics Inc. closed 5.99% below its 52-week high of $182.38, which the company achieved on June 16th.

Quest Diagnostics Incorporated (NYSE:DGX) is one of the 7 most undervalued pot stocks to buy according to analysts. On June ...

While DGX stock has been hammered in the market recently, the smart money may be sensing a bounce-back opportunity.

The lining on the inside of a nonstick pan is made of plastic. When heated, it can release toxic fumes; when scratched, it ...

The Durham-based parent company says it still plans to grow Q2 Solutions’ local headcount despite the grant terminations.

New York Giants rookies officially report for training camp on Tuesday, one week ahead of the remainder of the team.

Quest Diagnostics has signed up to offer a blood test that can help diagnose Alzheimer’s disease, following its FDA clearance earlier this year. | The Lumipulse G blood test measures the ratio between ...

Quest will offer the first FDA-approved blood test to help detect Alzheimer’s-related amyloid pathology in patients with ...

Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.